Julie E. Bauman, Lisa F. L. Licitra, Bhumsuk Keam, Neal Akhave, Muh-Hwa Yang, Kevin Joseph Harrington, Christine H. Chung, Sébastien Salas, Aurora Mirabile, Jessica R. Bauman, Nabil F. Saba, Deborah J.L. Wong, Christophe Le Tourneau, Suzy Muggeo, Bo Jin, Paulina Cox, Edgar E. Braendle, Robert I. Haddad. "FIERCE-HN: A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of ficlatuzumab (HGF/cMET mAb) in combination with cetuximab in participants with recurrent or metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps6132